4.6 Article

Synthesis of strong electron donating-accepting type organic fluorophore and its polypeptide nanoparticles for NIR-II phototheranostics

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.nano.2022.102574

Keywords

Nanotheranostic; Anticancer; NIR-II fluorescence imaging; Photothermal therapy

Funding

  1. National Key Research and Development Program of China [2020YFA0710700]
  2. National Natural Science Foundation of China [51873201, 82172071]
  3. Fundamental Research Funds for the CentralUniversities [YD2060002015]
  4. Key Research and Development Program of Anhui Province [202104b11020025]

Ask authors/readers for more resources

A novel NIR-II small-molecule organic fluorophore with strong electron-donating and accepting groups was synthesized and encapsulated into micelles. The resulting micelles showed excellent imaging performance and photothermal conversion efficiency, making it a promising platform for NIR-II imaging-guided photothermal therapy.
A novel NIR-II small-molecule D-A type organic fluorophore conjugation of triphenylamine, thiophene, and benzo[c,d] indol groups (TPA-Et) with strong electron-donating and accepting groups has been synthesized. The dye shows a significant Stokes shift for efficient fluorescence in the NIR-II region and high photothermal performance. The TPA-Et was then encapsulated by an amphiphilic copolymer P (OEGMA)20-P(Asp)14, and micelles (P@TP) has been prepared with outstanding NIR-II imaging performance, excellent photothermal conversion efficiency (52.5%) under 808 nm laser irradiation, and good photostability. Fluorescence imaging experiments have consistently shown that P@TP can image tiny blood vessels in mice, enrich effectively in the tumor region, and maintain a relatively stable NIR-II fluorescence signal in the tumor area for a long time up to 60 h. In vivo photothermal therapy has a highly significant anticancer effect without tumor recurrence, demonstrating the apparent advantages of P@TP as a NIR nanotheranostic platform in NIR-II imaging-guided photothermal therapy.(c) 2022 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available